News


Nature Biotechnology 25, 369 - 370 (2007)
Published online: 3 April 2007 | doi:10.1038/nbt0407-369

UK parses merits of value-based drug pricing

Nuala Moran1

  1. London


The UK's Office of Fair Trading is suggesting a system of drug pricing based on therapeutic value, which it believes would better focus innovation and investment toward creating more valuable drugs.

Top



Extra navigation

Search PubMed for

Open Innovation Challenges

naturejobs

ADVERTISEMENT